Literature DB >> 12202269

Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry.

Hema Ananth1, Ioana Popescu, Hugo D Critchley, Catriona D Good, Richard S J Frackowiak, Raymond J Dolan.   

Abstract

OBJECTIVE: Structural neuroimaging studies have suggested an association between schizophrenia and abnormalities in brain morphology such as ventricular enlargement and differences in gray matter distribution. Less consistently reported are findings of regional abnormalities such as selective differences in thalamic volume. The authors applied an unbiased technique to test for differences in cerebral morphometry between patients with schizophrenia and matched comparison subjects.
METHOD: T(1)-weighted images from 20 schizophrenic patients and matched comparison subjects were processed by using optimized automated voxel-based morphometry within multiple linear regression analyses.
RESULTS: Global differences in gray matter volume were seen between the schizophrenic and comparison subjects, with selective regional gray matter differences noted in the mediodorsal thalamus and across cortical regions, including the ventral and medial prefrontal cortices. Within the schizophrenic subjects, a relationship was observed between gray matter volume loss in the medial prefrontal cortex and a positive family history of schizophrenia. There was no significant difference between patients and comparison subjects in rates of proportional gray matter reduction with age.
CONCLUSIONS: These observations confirm an association between thalamocortical morphometric abnormalities and schizophrenia, consistent with theoretical models of primary pathoetiological dysfunction in filtering, integration, and information transfer processes in patients with schizophrenia.

Entities:  

Mesh:

Year:  2002        PMID: 12202269     DOI: 10.1176/appi.ajp.159.9.1497

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  41 in total

1.  Conceptualization and treatment of negative symptoms in schizophrenia.

Authors:  Sonali Sarkar; Kiley Hillner; Dawn I Velligan
Journal:  World J Psychiatry       Date:  2015-12-22

Review 2.  Testing models of thalamic dysfunction in schizophrenia using neuroimaging.

Authors:  K Sim; T Cullen; D Ongur; S Heckers
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

3.  Investigation of cortical thickness abnormalities in lithium-free adults with bipolar I disorder using cortical pattern matching.

Authors:  Lara C Foland-Ross; Paul M Thompson; Catherine A Sugar; Sarah K Madsen; Jim K Shen; Conor Penfold; Kyle Ahlf; Paul E Rasser; Jeffrey Fischer; Yilan Yang; Jennifer Townsend; Susan Y Bookheimer; Lori L Altshuler
Journal:  Am J Psychiatry       Date:  2011-02-01       Impact factor: 18.112

4.  Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study.

Authors:  Motoaki Nakamura; Dean F Salisbury; Yoshio Hirayasu; Sylvain Bouix; Kilian M Pohl; Takeshi Yoshida; Min-Seong Koo; Martha E Shenton; Robert W McCarley
Journal:  Biol Psychiatry       Date:  2007-06-27       Impact factor: 13.382

5.  Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study.

Authors:  In Kyoon Lyoo; Stephen R Dager; Jieun E Kim; Sujung J Yoon; Seth D Friedman; David L Dunner; Perry F Renshaw
Journal:  Neuropsychopharmacology       Date:  2010-03-31       Impact factor: 7.853

Review 6.  Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology.

Authors:  Alex Fornito; Murat Yücel; Brian Dean; Stephen J Wood; Christos Pantelis
Journal:  Schizophr Bull       Date:  2008-04-23       Impact factor: 9.306

7.  A large scale (N=400) investigation of gray matter differences in schizophrenia using optimized voxel-based morphometry.

Authors:  Shashwath A Meda; Nicole R Giuliani; Vince D Calhoun; Kanchana Jagannathan; David J Schretlen; Anne Pulver; Nicola Cascella; Matcheri Keshavan; Wendy Kates; Robert Buchanan; Tonmoy Sharma; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2008-04-18       Impact factor: 4.939

8.  A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.

Authors:  Holly Moore; J David Jentsch; Mehdi Ghajarnia; Mark A Geyer; Anthony A Grace
Journal:  Biol Psychiatry       Date:  2006-04-11       Impact factor: 13.382

9.  Progressive deformation of deep brain nuclei and hippocampal-amygdala formation in schizophrenia.

Authors:  Lei Wang; Daniel Mamah; Michael P Harms; Meghana Karnik; Joseph L Price; Mokhtar H Gado; Paul A Thompson; Deanna M Barch; Michael I Miller; John G Csernansky
Journal:  Biol Psychiatry       Date:  2008-09-23       Impact factor: 13.382

10.  The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis.

Authors:  Ian Ellison-Wright; David C Glahn; Angela R Laird; Sarah M Thelen; Ed Bullmore
Journal:  Am J Psychiatry       Date:  2008-04-01       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.